Jin Medical International (ZJYL) Gains from Sales and Divestitures (2023 - 2024)
Jin Medical International's (ZJYL) quarterly Gains from Sales and Divestitures came in at $2590.0 in Q1 2024, up 395.22% year-on-year from $523.0 in Q2 2023, and up 395.22% quarter-over-quarter from $523.0 in Q1 2023.
Jin Medical International (ZJYL) Gains from Sales and Divestitures (2023 - 2024) Analysis & Trends
Jin Medical International has disclosed Gains from Sales and Divestitures across 2 years of filings, most recently posting $2590.0 for Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Jin Medical International | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 2,590.00 |
| Mar 31, 2024 | 2,590.00 |
| Mar 31, 2023 | 523.00 |
| Mar 31, 2023 | 523.00 |